Bioorganic and Medicinal Chemistry p. 2115 - 2137 (2004)
Update date:2022-08-05
Topics:
Takami, Atsuya
Iwakubo, Masayuki
Okada, Yuji
Kawata, Takehisa
Odai, Hideharu
Takahashi, Nobuaki
Shindo, Kazutoshi
Kimura, Kaname
Tagami, Yoshimichi
Miyake, Mika
Fukushima, Kayoko
Inagaki, Masaki
Amano, Mutsuki
Kaibuchi, Kozo
Iijima, Hiroshi
Several structurally unrelated scaffolds of the Rho kinase inhibitor were designed using pharmacophore information obtained from the results of a high-throughput screening and structural information from a homology model of Rho kinase. A docking simulation using the ligand-binding pocket of the Rho kinase model helped to comprehensively understand and to predict the structure-activity relationship of the inhibitors. This understanding was useful for developing new Rho kinase inhibitors of higher potency and selectivity. We identified several potent platforms for developing the Rho kinase inhibitors, namely, pyridine, 1H-indazole, isoquinoline, and phthalimide.
View MoreSHANDONG CREDAGRI CHEMICAL CO., LTD.
Contact:+86-531-88872050
Address:ROOM 601A, BUILDING 2, SHUNTAI SQUARE, NO. 2000 SHUNHUA ROAD, HI-TECH DEVELOPMENT ZONE, JINAN, CHINA.
Hubei Onward Bio-Development Co., Ltd.
Contact:+86-718-8417012
Address:No.517,Shizhou Avenue,Enshi City,Hubei Province,China,445002
Yuan Shi(SuQian)Biotechnology Co.,Ltd
website:http://www.yuanshibio.com
Contact:+86-527-84226672
Address:jiangsu suqian
Shijiazhuang Yunxuan Im&Export Co.,Ltd.
Contact:+86-311-83037514
Address:No.6 Hongbin Road
Shijiazhuang Sdyano Fine Chemical Co., Ltd
Contact:+86-311-89830448
Address:NO.48 Ta Nan Road,Yuhua District,Shijiazhuang,Hebei,China
Doi:10.1007/BF01431320
(1996)Doi:10.1039/dt9960002857
(1996)Doi:10.1002/adsc.201500255
(2015)Doi:10.1016/0957-4166(96)00232-7
(1996)Doi:10.1021/ja304816e
(2012)Doi:10.1021/jo0300035
(2003)